Organization | Futian People's Hospital

Futian People's Hospital Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial

2014

NCT02289586

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 1 Trials (2)

naltrexone (revia) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

Drugs in Other Trials (5)

dezocine (dalgan) (1 trial)

fentanyl (Innovar) (1 trial)

midazolam (versed) (1 trial)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Arthritis (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 2
# of Trial APIs: 7